Related Experiment Video
Updated: Mar 12, 2026

06:08
Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
Published on: September 22, 2023
2.7K
Vitamin D and allergic rhinitis: A mini-review
1Medical Faculty, Sakarya University, Adapazarı 54100, Sakarya, Türkiye.
World Journal of Methodology
|March 11, 2026
Summary
Vitamin D may play a role in allergic rhinitis (AR) severity. While some studies link low vitamin D to worse AR, research on vitamin D supplementation for AR shows mixed results, needing more trials.
Area of Science:
- Immunology
- Allergology
- Endocrinology
Background:
- Allergic rhinitis (AR) is a prevalent inflammatory condition impacting global health.
- Vitamin D, an immunomodulatory hormone, is being investigated for its influence on allergic diseases like AR.
- Observational studies suggest a correlation between low serum 25-hydroxyvitamin D and increased AR prevalence, especially in children and males.
Purpose of the Study:
- To synthesize current evidence on the relationship between vitamin D levels and allergic rhinitis.
- To explore epidemiological findings and immunological mechanisms linking vitamin D and AR.
- To assess the potential of vitamin D as an adjunctive therapy for AR.
Main Methods:
- Review of epidemiological studies on vitamin D and AR prevalence.
- Analysis of immunological mechanisms of vitamin D's effect on immune responses.
- Evaluation of interventional studies on vitamin D supplementation for AR treatment.
Main Results:
- Observational data suggest a link between lower vitamin D levels and higher AR risk/severity.
- Interventional studies on vitamin D supplementation for AR have produced inconsistent results.
- Potential benefits of vitamin D may depend on individual factors like baseline levels, gender, and age.
Conclusions:
- Emerging evidence suggests vitamin D deficiency may worsen AR, but its therapeutic role is not definitively established.
- Further high-quality randomized controlled trials are necessary to clarify mechanisms and guide clinical practice.
- Individualized treatment strategies considering patient profiles are needed for optimal AR management with vitamin D.
Keywords:
1,25-dihydroxycholecalciferolAllergic rhinitisImmunoglobulin EImmunomodulationInflammationVitamin DMore Related Videos
Related Concept Videos
Allergic Reactions: Anaphylaxis
103
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
103
Allergic Reactions
33.2K
Overview
33.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.1K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.1K
Drugs Used in Lower Respiratory Disorders: Overview
1.4K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.4K
Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Allergic Drug Reactions
1.5K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.5K

